| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 04/07/2004 | EP1404328A1 Alpha-hydroxyamide statine derivatives for the treatment of alzheimer's disease |
| 04/07/2004 | EP1144436B1 METHOD FOR PREPARING BICYCLIC COMPOUNDS AND USE OF SAID METHOD FOR PREPARING AN INTERLEUKIN-1(Beta) CONVERSION ENZYME (ICE) INHIBITOR |
| 04/07/2004 | CN1144793C Polar-substituted hydrocarbons |
| 04/06/2004 | US6716968 Apoptosis-related antigenic compounds of specified amino acid sequence; inhibition of cell apoptosis; antibodies for stimulation of cell apoptosis; immunoassay to determine rate of apoptosis in tissues |
| 04/06/2004 | US6716869 N-(2-(1-amidinopyrrol-3-yl)ethyl)-5,6-dihydroxy-1-(2-(2-methox y-3-sulfatopropionylamino)-3-chloro-4-methylvaleroyl)indole-2-carboxamide |
| 04/06/2004 | US6716843 Inhibitor of dipeptidyl-peptidase iv |
| 04/06/2004 | US6716818 Caspase inhibitors and the use thereof |
| 04/06/2004 | US6716583 Methods of producing nucleic acid ligands |
| 04/01/2004 | WO2004026814A2 Process for the synthesis of intermediates useful for the synthesis of tubulin inhibitors |
| 04/01/2004 | WO2004026264A2 Novel aromatic compounds possessing antifungal or antibacterial activity |
| 04/01/2004 | WO2003099780A3 Luminogenic protease substrates |
| 04/01/2004 | WO2003054146A3 Self-assembly and mineralization of peptide-amphiphile nanofibers |
| 04/01/2004 | WO2002064131A3 Inflammation-inhibiting compounds |
| 04/01/2004 | US20040063904 Process for the synthesis of intermediates useful for the synthesis of tubulin inhibitors |
| 04/01/2004 | US20040063903 Wound healing agents; anticoagulants |
| 04/01/2004 | US20040063645 Such as ((2-(3-guanidino-2-hydroxy-propylcarbamoyl)-1H-indol-5-yl)-amide) |
| 04/01/2004 | US20040063642 Novel benzimidazolone peptidomimetics as thrombin receptor antagonists |
| 04/01/2004 | US20040063640 Inhibitor of glutathione s-transferase; anticancer agents |
| 04/01/2004 | US20040063623 Formulation of boronic acid compounds |
| 04/01/2004 | CA2498759A1 Process for the synthesis of intermediates useful for the synthesis of tubulin inhibitors |
| 03/31/2004 | EP1403278A1 Process for the synthesis of N-((S)-1-(ethoxycarbonyl)butyl)-(S)-alanine and use in the synthese of perindopril |
| 03/31/2004 | EP1403277A1 Method for synthesis of (2S,3aS,7aS)-1-((S)-alanyl)-octahydro-1H-indole-2-carboxylic acid derivatives and use in the synthesis of perindopril |
| 03/31/2004 | EP1403276A1 Synthesis of N-[N-(3,3-dimethylbutyl)-L-alpha-aspartyl]-L-phenylalanine 1-methyl ester using L-alpha-aspartyl-L-phenylalanine 1-methyl ester precursors |
| 03/31/2004 | EP1403275A1 Process for the synthesis of perindopril and its pharmaceutically acceptable salts |
| 03/31/2004 | EP1403265A1 Industrial process for the synthesis of 5-[bis(carboxymethyl)amino]-3-carboxymethyl-4-cyano-2-thiophene-carboxylic acid tetraesters and use for the synthesis of ranetic acid divalent salts and hydrates thereof |
| 03/31/2004 | EP1402899A1 Remedies for sepsis |
| 03/31/2004 | EP1402054A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 03/31/2004 | EP1402001A2 Anti-microbial peptides and compositions |
| 03/31/2004 | EP1401862A2 Peptide compounds for counteracting reactive oxygen species and free radicals |
| 03/31/2004 | EP1401808A2 Gpe analogs and peptidomimetics |
| 03/31/2004 | EP1401803A2 Method for producing chiral amino acid derivatives |
| 03/31/2004 | EP1401472A2 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 03/31/2004 | EP1401420A2 Perturbed membrane-binding compounds |
| 03/31/2004 | EP1401286A1 Method of inhibiting fungal growth |
| 03/31/2004 | EP1294742B1 Urokinase inhibitors |
| 03/31/2004 | EP1232174A4 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 03/31/2004 | EP0784677B1 Inhibitor of stem cell proliferation and uses thereof |
| 03/31/2004 | CN1486184A Lactam compound to inhibit beta-amyloid peptide release or synthesis |
| 03/31/2004 | CN1143863C Process for the quantitative synthesis of 3-(L-pyrolutamyl)-L-tiazolidine-4-carboxylic acid and derivatives thereof |
| 03/31/2004 | CN1143859C Camptothecin derivative and its preparation |
| 03/30/2004 | US6713628 Process for preparing pharmacologically acceptable salt of N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-amino acid |
| 03/30/2004 | US6713604 Synthetic cyclic peptides that inhibit that binding |
| 03/30/2004 | US6713603 Adjusted nucleotide sequences for use as antisense tools in genetic engineering |
| 03/30/2004 | US6713602 Compounds that are not polynucleotides yet which bind to complementary dna and rna strands more strongly the corresponding dna |
| 03/30/2004 | US6713487 Heterocyclic amine derivatives; for treating an inflammatory or immune disease, a cardiovascular disease, or a neurodegenerative condition |
| 03/30/2004 | US6713476 Substituted cycloalkyls as inhibitors of a beta protein production |
| 03/30/2004 | US6713472 Thiazine or pyrazine derivatives |
| 03/30/2004 | US6713446 Boronic acid compounds obtained by lyophilization of an aqueous mixture of the boronic acid compound and a sugar having at least two hydroxyl groups; shelf life |
| 03/30/2004 | US6713443 Compounds which modify serotoninergic transmission, diagnostic and therapeutic applications |
| 03/25/2004 | WO2004024755A2 Sarcolysyl derivatives and method for the production thereof |
| 03/25/2004 | WO2004024754A1 Proline ester and preparation containing the same for percutaneous administration |
| 03/25/2004 | WO2004024139A1 Melanin extinguisher |
| 03/25/2004 | WO2004005324A3 Peptide composition for treatment of sexual dysfunction |
| 03/25/2004 | WO2003104167A3 Cyanohydrin ethers and esters as high-sensitivity enzyme substrates |
| 03/25/2004 | WO2003097668A3 Novel process for production of the somatostatin analog, octreotide |
| 03/25/2004 | WO2003093314A3 Connective tissue stimulating peptides |
| 03/25/2004 | WO2003087069A3 Dipeptidic growth hormone secretagogues |
| 03/25/2004 | WO2003087050A3 Novel perindopril salt and pharmaceutical compositions containing same |
| 03/25/2004 | WO2003074546A3 Streptavidin-binding peptide |
| 03/25/2004 | WO2003072528A3 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| 03/25/2004 | WO2003070735A3 Components for producing amphoteric liposomes |
| 03/25/2004 | WO2003057721A3 Substituted amino carboxamides for the treatment of alzheimer's disease |
| 03/25/2004 | WO2003027081A3 NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER |
| 03/25/2004 | WO2003012122A8 Crystallized structure of type iv collagen nc1 domain hexamer |
| 03/25/2004 | US20040059134 Introducing in a reactor a5-amino-3-(carboxyalkyl)-4-cyano-2-thiophenecarboxylic acid, potassium carbonate and a quaternaryammonium salt as catalyst acetone solvent and methyl bromo acetate, heating and cooling |
| 03/25/2004 | US20040059087 Peptide nucleic acids |
| 03/25/2004 | US20040058877 Somatostatin antagonists and agonists that act at the sst subtype 2 receptor |
| 03/25/2004 | US20040058850 Using caspase inhibitor; antiinflammatory agents |
| 03/25/2004 | US20040057957 Agent for the treatment and/or prophylaxis of microcirculatory disorders |
| 03/25/2004 | US20040057925 Methods of enhancing bioactivity of chemokines |
| 03/25/2004 | CA2498757A1 Proline ester and preparation containing the same for percutaneous administration |
| 03/24/2004 | EP1400531A1 Process for the synthesis of N-((S)-1-(ethoxycarbonyl)butyl)-(S)-alanine and use in the synthesis of perindopril |
| 03/24/2004 | EP1400530A1 Suppression of immune response via inhibition of cathepsin S |
| 03/24/2004 | EP1400245A1 Boronic acid salts useful in parenteral formulations for selective thrombin inhibition |
| 03/24/2004 | EP1399469A2 Peptide structures useful for competitive modulation of dipeptidyl peptidase iv catalysis |
| 03/24/2004 | EP1399468A1 2-((n-(2-amino-3-(heteroaryl or aryl)propionyl)-aminoacyl)-amino)-alkylboronic acid derivatives |
| 03/24/2004 | EP1399467A2 Peptide deformylase activated prodrugs |
| 03/24/2004 | EP0784469B1 Compositions for the delivery of antigens |
| 03/24/2004 | EP0758341B1 FACTOR Xa INHIBITORS |
| 03/24/2004 | CN1484694A Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
| 03/24/2004 | CN1484526A Perturbed membrane-binding compounds |
| 03/24/2004 | CN1484497A Protein hydrol ysater enriched in peptides having a carboxy termina proline residue |
| 03/24/2004 | CN1483728A Process for preparation of oxo-oxazoline or alloamino acid derivatives |
| 03/23/2004 | US6710200 Using reporter molecule derivative having aldehyde or ketone group detectable by fluorescence emission, ultraviolet radiation, absorptivity or colorimetric analysis; rearrangements |
| 03/23/2004 | US6710164 Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility |
| 03/23/2004 | US6710163 Compounds that bind single-stranded dna and rna strands to form stable hybrids; bind complementary single-stranded dna and rna strands more strongly than corresponding dna |
| 03/23/2004 | US6710029 Dehydrodidemnin B |
| 03/18/2004 | WO2004022773A1 Fluorescent enzyme assay methods and compositions |
| 03/18/2004 | WO2004022737A1 Method of designing physiologically active peptide and use thereof |
| 03/18/2004 | WO2004022733A1 Novel enzyme forming peptide, microorganism producing the same and process for producing dipeptide using them |
| 03/18/2004 | WO2004022583A1 Versatile linker compound and ligand, and method for preparation thereof |
| 03/18/2004 | WO2004022582A1 Peptidomimetic drugs |
| 03/18/2004 | WO2004022072A1 Boronic acid salts ant their use in the treatment of thrombosis |
| 03/18/2004 | WO2004022071A1 Multivalent metal salts of boronic acids for treating thrombosis |
| 03/18/2004 | WO2004022070A1 Boronic acid salts useful in parenteral formulations for selective thrombin inhibition |
| 03/18/2004 | WO2004006962A3 A tissue factor binding immunoconjugate comprising factor viia |
| 03/18/2004 | WO2003089459A3 Thyrotropin-releasing hormone analogues and their therapeutic applications |
| 03/18/2004 | WO2003033524A3 Peptidyl ketones as inhibitors of dpiv |
| 03/18/2004 | WO2002096930A3 Iap binding peptides and assays for identifying compounds that bind iap |
| 03/18/2004 | US20040054143 Vegf peptides and their use for inhibiting angiogenesis |